Drug Screening Market

Drug Screening Market by Product ((Immunoassay Analyzer, Chromatography, Breathalyzer, Rapid Test Device, Assay Kits)), Drug Screening Services, Sample Type (Urine, Hair, Oral), End User (Workplace, Criminal Justice, Hospital) - Global Forecast to 2022

Report Code: MD 3239 Oct, 2019, by marketsandmarkets.com

[203 Pages Report] The drug screening market was valued at USD 4.86 Billion in 2016 and is expected to reach USD 8.63 Billion by 2022, growing at a CAGR of 10.2% during the forecast period. The base year considered for the study is 2016 and the forecast period is from 2017 to 2022.

Market Dynamics

Growing drug and alcohol consumption

Drug abuse and alcohol consumption are increasing across the globe. According to the United Nations Office on Drugs and Crime (UNODC), in 2015, about 5% of the global adult population consumed drugs at least once. Also, 0.6% of the global adult population suffers from drug use disorders. The extent of harm caused by drugs is equal to losing 28 million years of “healthy” life (disability-adjusted life years [DALYs]), globally. Of these, 17 million were primarily due to morbidity and mortality resulting from various types of drugs. To curb the menace of drug and alcohol abuse, authorities in various countries are focusing on implementing comprehensive drug and alcohol testing measures. Thus, the demand for drug and alcohol testing is expected to increase in the coming years.

Ban on alcohol consumption in several Islamic countries

Consumption of alcohol by the Muslim population is banned in Islamic countries, such as Pakistan, Afghanistan, Bahrain, Libya, Iran, UAE (Emirate of Sharjah), Kuwait, and Yemen. Alcohol consumption in these regions is a punishable offense and the offenders face harsh punishments. For instance, in Afghanistan, it is illegal to purchase alcohol. Similarly, in Iran, very strict laws have been implemented against the consumption of alcohol. As per Article 265 of the new Islamic Penal Code implemented in 2013, drinking alcohol is punishable by 80 lashes, irrespective of the gender of the offender. Also in some cases, the offender may be sentenced to death. Owing to religious regions, coupled with such strict punishments and stringent regulations, the consumption of alcohol in many Islamic countries is very less. This is a major restraint for the growth of the drug and alcohol testing market, especially the breathalyzers market in these countries.

Emergence of fingerprint-based drug screening

Globally, the prevalence of illegal consumption of drugs, such as cannabis, opioids, opiates, cocaine, amphetamines, and ecstasy is on the rise. The annual prevalence of the use of these drugs was 3.6% of the total adult population in 2011 and increased to 5.3% in 2015 (source: United Nations Office on Drugs and Crime). This growing burden of drug addiction creates the need to develop technologically advanced products for drug screening.

Fingerprint-based drug testing is a relatively new concept. It is non-invasive, less time consuming, portable, hygienic, user-friendly, and requires no specific preparation for sample collection and handling. This test is very easy to implement whenever and wherever it is required, thus offering flexible and effective means of supporting workplace drug testing policies. This test works by analyzing the small traces of sweat in the fingerprint to detect drug and drug metabolites. This test is used in workplaces, criminal justice and law enforcement agencies, and drug rehabilitation programs.

Currently, the market for fingerprint-based drug testing is at its infancy stage and is expected to grow at a slower pace compared to other drug testing samples. Intelligent Fingerprint (UK) is the first player to gain entry into this market. In September 2017, the company launched its fingerprint-based drug screening system (consists of the sample collection cartridge and reader analyzer 1000 analysis unit), which is the only product of its kind available in the market. This system can simultaneously screen 4 main drug groups—cocaine, opiates, amphetamines, and cannabis—within 10 minutes of sample collection. If this test is widely adopted, it is expected to replace urine, hair, and blood-based drug tests. This is a significant opportunity for the market players to capitalize on in the drug screening market.

The objectives of this study are as follows:

  • To define, describe, segment, and forecast the global market by product and service, sample type, end user, and region To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, challenges, and market-specific trends)
  •  To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze the opportunities in the market for stakeholders and provide details of competitive landscape for market leaders
  • To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). To profile key players and comprehensively analyze their market shares and core competencies
  • To track and analyze competitive developments such as agreements, partnerships, and collaborations; acquisitions; product launches and approvals; expansions; and R&D activities in the global market.

Research Methodology

The study estimates the drug screening market size for 2017 and projects its demand till 2022. In the primary research process, various sources from both demand side and supply side were interviewed to obtain qualitative and quantitative information for the report. Primary sources from the demand side include various industry CEOs, vice presidents, marketing directors, technology and innovation directors, and related key executives from the various players in the market. For the market estimation process, both top-down and bottom-up approaches were used to estimate and validate the market size of the market as well as to estimate the market size of various other dependent submarkets. All possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. This data was consolidated and added to detailed inputs and analysis from MarketsandMarkets and presented in this report.

Drug Screening Market

To know about the assumptions considered for the study, download the pdf brochure

The drug screening market is highly competitive with the presence of several big and small players. Prominent players offering products for drug screening include Alere (US), Thermo Fisher (US), Drδgerwerk (Germany), OraSure (US), Alfa Scientific Designs (US), Lifeloc (US), MPD, Inc. (US), Premier Biotech (US), Shimadzu (Japan), Siemens Healthineers (US). On the other hand, LabCorp (US), Quest Diagnostics (US), Omega Laboratories (US), Psychemedics (US), CRL (US), SureHire (Canada), and CannAmm (Canada), are key players in the market.

Target Audience for this Report:

  • Drug and alcohol testing laboratories
  • Drug and alcohol testing product manufacturing companies
  • Rapid drug screening device manufacturers
  • Law enforcement agencies
  • Healthcare providers
  • Government agencies
  • Research and consulting firms
  • Venture capitalists

Scope of the Report : Drug Screening Market

This report categorizes the market into following segments and subsegments:

By Product & Services

  • Drug Screening  Products
    • Analytical Instruments
      • Immunoanalyzers
      • Chromatography Instruments
      • Breathalyzers
        • Fuel-cell breathalyzer
        • Semi-conductor breathalyzer
        • Other breathalyzers
    • Rapid Testing Devices
      • Urine testing device
        • Drug testing cups
        • Dip cards
        • Drug Testing Cassettes
      • Oral Fluid Testing Devices
    • Consumables
      • Assay Kits
      • Sample Collection devices
      • Calibrators & Controls
      • *Other consumables
  • Drug Screening Services

By Sample Type

  • Urine
  • Breath
  • Oral Fluid
  • Hair
  • Other Samples

By End User

  • Workplace
  • Criminal Justice Systems and Law Enforcement Agencies
  • Drug Treatment Centers
  • Pain Management Centers
  • Schools and Colleges
  • Hospitals
  • Individual users
  • Drug testing laboratories

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • RoE
  • Asia Pacific
  • Rest of the World (RoW)

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company‘s specific needs.

The following customization options are available for this report.

Company Information

Detailed analysis and profiling of additional market players (up to 5)

Product Analysis

Product Matrix, which gives a detailed comparison of product portfolios of the top companies

The global drug screening market is projected to reach USD 8.63 Billion by 2022 from USD 5.32 Billion in 2017, at a CAGR of 10.2%. Factors such as growing drug & alcohol consumption, enforcement of stringent laws mandating drug and alcohol testing, and regulatory approvals and new product & service launches are driving the growth of the market.

The report segments the global market by product and service, sample type, end user, and region.

Based on product, the market is segmented into analytical instruments, rapid testing devices, and consumables. Rapid testing devices market is further subsegmented into urine testing devices and oral fluid testing devices. The urine testing devices segment is expected to account for the largest market share in 2017. However, the oral fluid testing devices segment is projected to register highest CAGR during the forecast period. The high growth in this segment is attributed to the benefits it offers such as shorter detection window, non-invasive nature, and low risk of sample tampering.

The global market by sample type is segmented into urine, breath, oral fluid, hair, and other samples. The urine sample segment is estimated to account for the largest share in 2017, however, the oral fluid samples segment is expected to register the highest growth rate during the forecast period.

Based on end users, the market is segmented into workplaces, criminal justice systems and law enforcement, drug treatment centers, pain management centers, schools and colleges, hospitals, individual users, and drug testing laboratories. In 2017, the workplace testing segment is expected to account for the largest share of the market. The growth of this end-user segment can be attributed to the growing safety concerns in the workplace and the increasing number of organizations that have made regular drug screening mandatory.

Drug Screening Market

The market is dominated by North America, followed by Europe, Asia Pacific, and the Rest of the World (RoW). The dominance of the North American market is attributed to factors such as rising consumption of illicit drugs, availability of government funding to curb drug abuse, and the presence of laws supporting drug screening, and growing burden of accidents due to unsafe levels of alcohol consumption.

While the market represents significant growth opportunities, market growth may be hindered due to prohibition of drug testing at workplace in certain regions, and ban on alcohol consumption in Islamic countries. The Drug Screening Market is highly competitive with presence of several big and small players. Prominent players offering drug screening products include Alere (US), Thermo Fisher (US), Drδgerwerk (Germany), OraSure (US), Alfa Scientific Designs (US), Lifeloc (US), MPD, Inc. (US), Premier Biotech (US), Shimadzu (Japan), Siemens Healthineers (US). While, LabCorp (US), Quest Diagnostics (US), Omega Laboratories (US), Psychemedics (US), CRL (US), SureHire (Canada), and CannAmm (Canada) are some of key players offering drug screening services.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 18)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Market Stakeholders

2 Research Methodology (Page No. - 21)
    2.1 Research Data
    2.2 Secondary Data
           2.2.1 Secondary Sources
    2.3 Primary Data
           2.3.1 Primary Sources
           2.3.2 Key Industry Insights
    2.4 Market Estimation
    2.5 Market Breakdown and Data Triangulation
    2.6 Assumptions for the Study

3 Executive Summary (Page No. - 29)

4 Premium Insights (Page No. - 33)
    4.1 Attractive Opportunities in Market
    4.2 Drug Screening Market, By Product
    4.3 Geographical Analysis Europe Market, By Product and Country
    4.4 Market, By Sample Type
    4.5 Market, By End User
    4.6 Market: Geographic Snapshot

5 Market Overview (Page No. - 38)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Growing Drug & Alcohol Consumption
                    5.2.1.2 Enforcement of Stringent Laws Mandating Drug and Alcohol Testing
                    5.2.1.3 Presence of Government Funding in Major Markets
                    5.2.1.4 Regulatory Approvals & Product Launches and Services
           5.2.2 Restraints
                    5.2.2.1 Ban on Alcohol Consumption in Several Islamic Countries
                    5.2.2.2 Prohibition of Workplace Drug Testing in Some Countries
           5.2.3 Opportunities
                    5.2.3.1 Oral Fluid Testing
                    5.2.3.2 Emergence of Fingerprint-Based Drug Screening
                    5.2.3.3 Emerging Economies
           5.2.4 Challenges
                    5.2.4.1 Accuracy and Specificity Concerns Related to Breathalyzers

6 Drug Screening Market, By Product & Service (Page No. - 44)
    6.1 Introduction
    6.2 Drug Screening Products
           6.2.1 Analytical Instruments
                    6.2.1.1 Immunoassay Analyzers
                    6.2.1.2 Chromatography Instruments
                    6.2.1.3 Breathalyzers
                               6.2.1.3.1 Fuel Cell Breathalyzers
                               6.2.1.3.2 Semiconductor Breathalyzers
                               6.2.1.3.3 Other Breathalyzers
           6.2.2 Rapid Testing Devices
                    6.2.2.1 Urine Testing Devices
                               6.2.2.1.1 Drug Testing Cups
                               6.2.2.1.2 DIP Cards
                               6.2.2.1.3 Drug Testing Cassettes
                    6.2.2.2 Oral Fluid Testing Devices
           6.2.3 Consumables
                    6.2.3.1 Assay Kits
                    6.2.3.2 Sample Collection Devices
                    6.2.3.3 Calibrators and Controls
                    6.2.3.4 Other Consumables
    6.3 Drug Screening Services

7 Drug Screening Market, By Sample Type (Page No. - 78)
    7.1 Introduction
    7.2 Urine Samples
    7.3 Breath Samples
    7.4 Oral Fluid Samples
    7.5 Hair Samples
    7.6 Other Samples

8 Drug Screening Market, By End User (Page No. - 89)
    8.1 Introduction
    8.2 Workplace
    8.3 Criminal Justice Systems and Law Enforcement Agencies
    8.4 Drug Treatment Centers
    8.5 Pain Management Centers
    8.6 Schools and Colleges
    8.7 Hospitals
    8.8 Individual Users
    8.9 Drug Testing Laboratories

9 Drug Screening Market, By Region (Page No. - 104)
    9.1 Introduction
    9.2 North America
           9.2.1 US
           9.2.2 Canada
    9.3 Europe
           9.3.1 Germany
           9.3.2 France
           9.3.3 UK
           9.3.4 Rest of Europe (RoE)
    9.4 Asia Pacific
    9.5 Rest of the World (RoW)

10 Competitive Landscape (Page No. - 150)
     10.1 Introduction
     10.2 Rapid Testing Devices, Ranking of Key Player (2016)
     10.3 Drug Screening Services Market, Ranking of Key Player (2016)
     10.4 Competitive Scenario
             10.4.1 Product Launches and Approvals
             10.4.2 Expansions
             10.4.3 Agreements, Partnerships, and Collaborations
             10.4.4 Acquisitions

11 Company Profiles (Page No. - 156)
(Business Overview, Products Offered, SWOT Anlysis, MnM View.)*
     11.1 Alere
     11.2 Thermo Fisher Scientific
     11.3 Drδgerwerk
     11.4 Labcorp
     11.5 Quest Diagnostics
     11.6 Alfa Scientific Designs
     11.7 Lifeloc
     11.8 MPD Inc.
     11.9 Orasure
     11.10 Omega Laboratories
     11.11 Premier Biotech
     11.12 Psychemedics
     11.13 Roche
     11.14 Shimadzu
     11.15 Siemens Healthineers

*Business Overview, Products Offered, SWOT Anlysis, MnM View Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 194)
     12.1 Insights Form Industry Experts
     12.2 Discussion Guide
     12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.4 Introducing RT: Real-Time Market Intelligence
     12.5 Available Customizations
     12.6 Related Reports
     12.7 Author Details


List of Tables (204 Tables)

Table 1 Key Product & Service Launches (2014–2017)
Table 2 Recent Approvals for Drug and Alcohol Testing Products and Services
Table 3 Drug Screening Market: Staregic Developments in Emerging Markets
Table 4 Drug Screening Products & Services Market, By Type, 2015–2022 (USD Million)
Table 5 Drug Screening Products Market, By Type, 2015–2022 (USD Million)
Table 6 Drug Screening Products Market for Analytical Instruments, By, Type, 2015–2022 (USD Million)
Table 7 Drug Screening Products Market for Analytical Instruments, By Region, 2015–2022 (USD Million)
Table 8 North America: Drug Screening Products Market for Analytical Instruments, By Country, 2015–2022 (USD Million)
Table 9 Europe: Drug Screening Products Market for Analytical Instruments, By Country, 2015–2022 (USD Million)
Table 10 Immunoassay Analyzers Market, By Region, 2015–2022 (USD Million)
Table 11 North America: Immunoassay Analyzers Market, By Country, 2015–2022 (USD Million)
Table 12 Europe: Immunoassay Analyzers Market, By Country, 2015–2022 (USD Million)
Table 13 Chromatography Instruments Market, By Region, 2015–2022 (USD Million)
Table 14 North America: Chromatography Instruments Market, By Country, 2015–2022 (USD Million)
Table 15 Europe: Chromatography Instruments Market, By Country, 2015–2022 (USD Million)
Table 16 Breathalyzers Market, By Type, 2015–2022 (USD Million)
Table 17 Breathalyzers Market, By Region, 2015–2022 (USD Million)
Table 18 North America: Breathalyzers Market, By Country, 2015–2022 (USD Million)
Table 19 Europe: Breathalyzers Market, By Country, 2015–2022 (USD Million)
Table 20 Fuel Cell Breathalyzers Market, By Region, 2015–2022 (USD Million)
Table 21 North America: Fuel Cell Breathalyzers Market, By Country, 2015–2022 (USD Million)
Table 22 Europe: Fuel Cell Breathalyzers Market, By Country, 2015–2022 (USD Million)
Table 23 Semiconductor Breathalyzers Market, By Region, 2015–2022 (USD Million)
Table 24 North America: Semiconductor Breathalyzers Market, By Country, 2015–2022 (USD Million)
Table 25 Europe: Semiconductor Breathalyzers Market, By Country, 2015–2022 (USD Million)
Table 26 Other Breathalyzers Market, By Region, 2015–2022 (USD Million)
Table 27 North America: Other Breathalyzers Market, By Country, 2015–2022 (USD Million)
Table 28 Europe: Other Breathalyzers Market, By Country, 2015–2022 (USD Million)
Table 29 Drug Screening Products Market for Rapid Testing Devices, By Type, 2015–2022 (USD Million)
Table 30 Drug Screening Products Market for Rapid Testing Devices, By Region, 2015–2022 (USD Million)
Table 31 North America: Drug Screening Products Market for Rapid Testing Devices, By Country, 2015–2022 (USD Million)
Table 32 Europe: Drug Screening Products Market for Rapid Testing Devices, By Country, 2015–2022 (USD Million)
Table 33 Urine Testing Devices Market, By Type, 2015–2022 (USD Million)
Table 34 Urine Testing Devices Market, By Region, 2015–2022 (USD Million)
Table 35 North America: Urine Testing Devices Market, By Country, 2015–2022 (USD Million)
Table 36 Europe: Urine Testing Devices Market, By Country, 2015–2022 (USD Million)
Table 37 Drug Testing Cups Market, By Region, 2015–2022 (USD Million)
Table 38 North America: Drug Testing Cups Market, By Country, 2015–2022 (USD Million)
Table 39 Europe: Drug Testing Cups Market, By Country, 2015–2022 (USD Million)
Table 40 DIP Cards Market, By Region, 2015–2022 (USD Million)
Table 41 North America: DIP Cards Market, By Country, 2015–2022 (USD Million)
Table 42 Europe: DIP Cards Market, By Country, 2015–2022 (USD Million)
Table 43 Drug Testing Cassettes Market, By Region, 2015–2022 (USD Million)
Table 44 North America: Drug Testing Cassettes Market, By Country, 2015–2022 (USD Million)
Table 45 Europe: Drug Testing Cassettes Market, By Country, 2015–2022 (USD Million)
Table 46 Oral Fluid Testing Devices Market, By Region, 2015–2022 (USD Million)
Table 47 North America: Oral Fluid Testing Devices Market, By Country, 2015–2022 (USD Million)
Table 48 Europe: Oral Fluid Testing Devices Market, By Country, 2015–2022 (USD Million)
Table 49 Drug Screening Consumables Market, By Type, 2015–2022 (USD Million)
Table 50 Drug Screening Consumables Market, By Region, 2015–2022 (USD Million)
Table 51 North America: Drug Screening Consumables Market, By Country, 2015–2022 (USD Million)
Table 52 Europe: Drug Screening Consumables Market, By Country, 2015–2022 (USD Million)
Table 53 Assay Kits Market, By Region, 2015–2022 (USD Million)
Table 54 North America: Assay Kits Market, By Country, 2015–2022 (USD Million)
Table 55 Europe: Assay Kits Market, By Country, 2015–2022 (USD Million)
Table 56 Sample Collection Devices Market, By Region, 2015–2022 (USD Million)
Table 57 North America: Sample Collection Devices Market, By Country, 2015–2022 (USD Million)
Table 58 Europe: Sample Collection Devices Market, By Country, 2015–2022 (USD Million)
Table 59 Calibrators and Controls Market, By Region, 2015–2022 (USD Million)
Table 60 North America: Calibrators and Controls Market, By Country, 2015–2022 (USD Million)
Table 61 Europe: Calibrators and Controls Market, By Country, 2015–2022 (USD Million)
Table 62 Other Consumables Market, By Region, 2015–2022 (USD Million)
Table 63 North America: Other Consumables Market, By Country, 2015–2022 (USD Million)
Table 64 Europe: Other Consumables Market, By Country, 2015–2022 (USD Million)
Table 65 Drug Screening Services Market, By Region, 2015–2022 (USD Million)
Table 66 North America: Drug Screening Services Market, By Country, 2015–2022 (USD Million)
Table 67 Europe: Drug Screening Services Market, By Country, 2015–2022 (USD Million)
Table 68 Drug Screening Market, By Sample Type, 2015–2022 (USD Million)
Table 69 Market for Urine Samples, By Region, 2015–2022 (USD Million)
Table 70 North America: Market for Urine Samples, By Country, 2015–2022 (USD Million)
Table 71 Europe: Market for Urine Samples, By Country, 2015–2022 (USD Million)
Table 72 Market for Breath Samples, By Region, 2015–2022 (USD Million)
Table 73 North America: Market for Breath Samples, By Country, 2015–2022 (USD Million)
Table 74 Europe: Market for Breath Samples, By Country, 2015–2022 (USD Million)
Table 75 Market for Oral Fluid Samples, By Region, 2015–2022 (USD Million)
Table 76 North America: Market for Oral Fluid Samples, By Country, 2015–2022 (USD Million)
Table 77 Europe: Market for Oral Fluid Samples, By Country, 2015–2022 (USD Million)
Table 78 Market for Hair Samples, By Region, 2015–2022 (USD Million)
Table 79 North America: Market for Hair Samples, By Country, 2015–2022 (USD Million)
Table 80 Europe: Market for Hair Samples, By Country, 2015–2022 (USD Million)
Table 81 Market for Other Samples, By Region, 2015–2022 (USD Million)
Table 82 North America: Market for Other Samples, By Country, 2015–2022 (USD Million)
Table 83 Europe: Drug Screening Market for Other Samples, By Country, 2015–2022 (USD Million)
Table 84 Market, By End User, 2015–2022 (USD Million)
Table 85 Market for Workplace, By Region, 2015–2022 (USD Million)
Table 86 North America: Market for Workplace, By Country, 2015–2022 (USD Million)
Table 87 Europe: Market for Workplace, By Country, 2015–2022 (USD Million)
Table 88 Market for Criminal Justice and Law Enforcement Agencies, By Region, 2015–2022 (USD Million)
Table 89 North America: Market Criminal Justice and Law Enforcement Agencies, By Country, 2015–2022 (USD Million)
Table 90 Europe: Drug Screening Market Criminal Justice and Law Enforcement Agencies, By Country, 2015–2022 (USD Million)
Table 91 Market for Drug Treatment Centers, By Region, 2015–2022 (USD Million)
Table 92 North America: Market for Drug Treatment Centers, By Country, 2015–2022 (USD Million)
Table 93 Europe: Market for Drug Treatment Centers, By Country, 2015–2022 (USD Million)
Table 94 Market for Pain Management Centers, By Region, 2015–2022 (USD Million)
Table 95 North America: Market Pain Management Centers, By Country, 2015–2022 (USD Million)
Table 96 Europe: Market Pain Management Centers, By Country, 2015–2022 (USD Million)
Table 97 Market for Schools and Colleges, By Region, 2015–2022 (USD Million)
Table 98 North America: Market Schools and Colleges, By Country, 2015–2022 (USD Million)
Table 99 Europe: Market for Schools and Colleges, By Country, 2015–2022 (USD Million)
Table 100 Market for Hospitals, By Region, 2015–2022 (USD Million)
Table 101 North America: Drug Screening Market for Hospitals, By Country, 2015-2022 (USD Million)
Table 102 Europe: Market for Hospitals, By Country, 2015-2022 (USD Million)
Table 103 Market for Individual Users, By Region, 2015-2022 (USD Million)
Table 104 North America: Market for Individual Users, By Country, 2015-2022 (USD Million)
Table 105 Europe: Market for Individual Users, By Country, 2015-2022 (USD Million)
Table 106 Market for Drug Testing Laboratories, By Region, 2015-2022 (USD Million)
Table 107 North America: Market for Drug Testing Laboratories, By Country, 2015-2022 (USD Million)
Table 108 Europe: Drug Screening Market for Drug Testing Laboratories, By Country, 2015–2022 (USD Million)
Table 109 Global Market, By Region, 2015-2022, (USD Million)
Table 110 North America: Market, By Country, 2015-2022 (USD Million)
Table 111 North America: Market, By Product & Service, 2015-2022 (USD Million)
Table 112 North America: Market, By Product, 2015-2022 (USD Million)
Table 113 North America: Analytical Instruments Market, By Type, 2015-2022 (USD Million)
Table 114 North America: Breathalyzers Market, By Type, 2015-2022 (USD Million)
Table 115 North America: Rapid Testing Devices Market, By Type, 2015-2022 (USD Million)
Table 116 North America: Urine Testing Devices Market, By Type, 2015-2022 (USD Million)
Table 117 North America: Consumables Market, By Type, 2015-2022 (USD Million)
Table 118 North America: Drug Screening Market, By Sample Type, 2015-2022 (USD Million)
Table 119 North America: Market, By End User, 2015-2022 (USD Million)
Table 120 US: Market, By Product & Service, 2015-2022 (USD Million)
Table 121 US: Market, By Product, 2015-2022 (USD Million)
Table 122 US: Analytical Instruments Market, By Type, 2015-2022 (USD Million)
Table 123 US: Breathalyzers Market, By Type, 2015-2022 (USD Million)
Table 124 US: Rapid Testing Devices Market, By Type, 2015-2022 (USD Million)
Table 125 US: Urine Testing Devices Market, By Type, 2015-2022 (USD Million)
Table 126 US: Consumables Market, By Type, 2015-2022 (USD Million)
Table 127 US: Drug Screening Market, By Sample Type, 2015-2022 (USD Million)
Table 128 US: Market, By End User, 2015-2022 (USD Million)
Table 129 Canada: Market, By Product & Service, 2015-2022 (USD Million)
Table 130 Canada: Market, By Product, 2015-2022 (USD Million)
Table 131 Canada: Analytical Instruments Market, By Type, 2015-2022 (USD Million)
Table 132 Canada: Breathalyzers Market, By Type, 2015-2022 (USD Million)
Table 133 Canada: Rapid Testing Devices Market, By Type, 2015-2022 (USD Million)
Table 134 Canada: Urine Testing Devices Market, By Type, 2015-2022 (USD Million)
Table 135 Canada: Consumables Market, By Type, 2015-2022 (USD Million)
Table 136 Canada: Market, By Sample Type, 2015-2022 (USD Million)
Table 137 Canada: Drug Screening Market, By End User, 2015-2022 (USD Million)
Table 138 Europe: Market, By Country, 2015-2022, (USD Million)
Table 139 Europe: Drug Screening Market, By Product & Service, 2015-2022 (USD Million)
Table 140 Europe: Market, By Product, 2015-2022 (USD Million)
Table 141 Europe: Analytical Instruments Market, By Type, 2015-2022 (USD Million)
Table 142 Europe: Breathalyzers Market, By Type, 2015-2022 (USD Million)
Table 143 Europe: Rapid Testing Devices Market, By Type, 2015-2022 (USD Million)
Table 144 Europe: Urine Testing Devices Market, By Type, 2015-2022 (USD Million)
Table 145 Europe: Consumables Market, By Type, 2015-2022 (USD Million)
Table 146 Europe: Market, By Sample Type, 2015-2022 (USD Million)
Table 147 Europe: Market, By End User, 2015-2022 (USD Million)
Table 148 Germany: Market, By Product & Service, 2015-2022 (USD Million)
Table 149 Germany: Drug Screening Market, By Product, 2015-2022 (USD Million)
Table 150 Germany: Analytical Instruments Market, By Type, 2015-2022 (USD Million)
Table 151 Germany: Breathalyzers Market, By Type, 2015-2022 (USD Million)
Table 152 Germany: Rapid Testing Devices Market, By Type, 2015-2022 (USD Million)
Table 153 Germany: Urine Testing Devices Market, By Type, 2015-2022 (USD Million)
Table 154 Germany: Consumables Market, By Type, 2015-2022 (USD Million)
Table 155 Germany: Drug Screening Market, By Sample Type, 2015-2022 (USD Million)
Table 156 Germany: Market, By End User, 2015-2022 (USD Million)
Table 157 France: Drug Screening Market, By Product & Service, 2015-2022 (USD Million)
Table 158 France: Market, By Product, 2015-2022 (USD Million)
Table 159 France: Analytical Instruments Market, By Type, 2015-2022 (USD Million)
Table 160 France: Breathalyzers Market, By Type, 2015-2022 (USD Million)
Table 161 France: Rapid Testing Devices Market, By Type, 2015-2022 (USD Million)
Table 162 France: Urine Testing Devices Market, By Type, 2015-2022 (USD Million)
Table 163 France: Consumables Market, By Type, 2015-2022 (USD Million)
Table 164 France: Drug Screening Market, By Sample Type, 2015-2022 (USD Million)
Table 165 France: Market, By End User, 2015-2022 (USD Million)
Table 166 UK: Market, By Product & Service, 2015-2022 (USD Million)
Table 167 UK: Market, By Product, 2015-2022 (USD Million)
Table 168 UK: Analytical Instruments Market, By Type, 2015-2022 (USD Million)
Table 169 UK: Breathalyzers Market, By Type, 2015-2022 (USD Million)
Table 170 UK: Rapid Testing Devices Market, By Type, 2015-2022 (USD Million)
Table 171 UK: Urine Testing Devices Market, By Type, 2015-2022 (USD Million)
Table 172 UK: Consumables Market, By Type, 2015-2022 (USD Million)
Table 173 UK: Drug Screening Market, By Sample Type, 2015-2022 (USD Million)
Table 174 UK: Market, By End User, 2015-2022 (USD Million)
Table 175 RoE: Market, By Product & Service, 2015-2022 (USD Million)
Table 176 RoE: Market, By Product, 2015-2022 (USD Million)
Table 177 RoE: Analytical Instruments Market, By Type, 2015-2022 (USD Million)
Table 178 RoE: Breathalyzers Market, By Type, 2015-2022 (USD Million)
Table 179 RoE: Rapid Testing Devices Market, By Type, 2015-2022 (USD Million)
Table 180 RoE: Urine Testing Devices Market, By Type, 2015-2022 (USD Million)
Table 181 RoE: Consumables Market, By Type, 2015-2022 (USD Million)
Table 182 RoE: Drug Screening Market, By Sample Type, 2015-2022 (USD Million)
Table 183 RoE: Market, By End User, 2015-2022 (USD Million)
Table 184 APAC: Market, By Product & Service, 2015-2022 (USD Million)
Table 185 APAC: Market, By Product, 2015-2022 (USD Million)
Table 186 APAC: Analytical Instruments Market, By Type, 2015-2022 (USD Million)
Table 187 APAC: Breathalyzers Market, By Type, 2015-2022 (USD Million)
Table 188 APAC: Rapid Testing Devices Market, By Type, 2015-2022 (USD Million)
Table 189 APAC: Urine Testing Devices Market, By Type, 2015-2022 (USD Million)
Table 190 APAC: Consumables Market, By Type, 2015-2022 (USD Million)
Table 191 APAC: Drug Screening Market, By Sample Type, 2015-2022 (USD Million)
Table 192 APAC: Market, By End User, 2015-2022 (USD Million)
Table 193 RoW: Market, By Product & Service, 2015-2022 (USD Million)
Table 194 RoW: Market, By Product, 2015-2022 (USD Million)
Table 195 RoW: Analytical Instruments Market, By Type, 2015-2022 (USD Million)
Table 196 RoW: Breathalyzers Market, By Type, 2015-2022 (USD Million)
Table 197 RoW: Rapid Testing Devices Market, By Type, 2015-2022 (USD Million)
Table 198 RoW: Urine Testing Devices Market, By Type, 2015-2022 (USD Million)
Table 199 RoW: Consumables Market, By Type, 2015-2022 (USD Million)
Table 200 RoW: Market, By Sample Type, 2015-2022 (USD Million)
Table 201 RoW: Drug Screening Market, By End User, 2015-2022 (USD Million)
Table 202 Market Ranking (2016) By Key Player: Drug Screening Services Market
Table 203 Product Launches and Approvals
Table 204 Exchange Rates (Utilized for Conversion of Jpy to USD)


List of Figures (42 Figures)

Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company, Designation, and Region
Figure 3 Bottom Up Approach
Figure 4 Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Drug Screening Services Market to Offer Significant Growth Opportunities
Figure 7 Analytical Instruments to Dominate the Drug Screening Products Market in 2017
Figure 8 Oral Fluid Sample to Witness High Growth During the Forecast Period (2017–2022)
Figure 9 Workplace Drug Testing to Dominate the Drug Screening Market in 2017
Figure 10 Asia Pacific to Witness High Growth During the Forecast Period
Figure 11 Growing Consumption of Drugs and Alcohol to Drive the Growth of the Market
Figure 12 Rapid Testing Devices to Witness High Growth During the Forecast Period
Figure 13 Assay Kits Segment to Account for the Largest Share of Drug Screening Consumables Market in 2017
Figure 14 Oral Fluid Sample Segment to Witness High Growth During the Forecast Period
Figure 15 Criminal Justice and Law Enforcement to Witness High Growth in the Forecast Period
Figure 16 US to Witness Highest Growth During the Forecast Period
Figure 17 Drug Screening Market: Drivers, Restraints, Opportunities, and Challenges
Figure 18 Market Snapshot, 2017 vs 2022
Figure 19 Drug Screening Products Market Segmentation
Figure 20 Analytical Instruments to Dominate the Drug Screening Products Market in 2017
Figure 21 Breathalyzers to Witness High Growth During the Forecast Period
Figure 22 Fuel Cell Breathalyzers to Dominate the Overall Breathalyzers Market in 2017
Figure 23 Assay Kits to Dominate the Drug Screening Consumables Market in 2017
Figure 24 Urine Samples Segment to Dominate the Market During the Forecast Period
Figure 25 Workplaces Segment to Dominate Market During the Forecast Period
Figure 26 North America to Dominate the Drug Screening Market in 2017
Figure 27 North America: Market Snapshot, 2017
Figure 28 Europe: Market Snapshot, 2017
Figure 29 Asia Pacific (APAC): Market Snapshot, 2017
Figure 30 RoW: Market Snapshot, 2017
Figure 31 Market Evolution Framework
Figure 32 Alere: Company Snapshot (2016)
Figure 33 Thermo Fisher Scientific: Company Snapshot (2016)
Figure 34 Drδgerwerk: Company Snapshot (2016)
Figure 35 Labcorp: Company Snapshot (2016)
Figure 36 Quest Diagnostics: Company Snapshot (2016)
Figure 37 Lifeloc: Company Snapshot (2016)
Figure 38 Orasure: Company Snapshots (2016)
Figure 39 Psychemedics: Company Snapshot (2016)
Figure 40 Roche: Company Snapshot (2016)
Figure 41 Shimadzu: Company Snapshot (2016)
Figure 42 Siemens: Company Snapshot (2016)


Request for detailed methodology, assumptions & how numbers were triangulated.

Please share your problem/objectives in greater details so that our analyst can verify if they can solve your problem(s).
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
MD 3239
Published ON
Oct, 2019
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Drug Screening Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

...

Digital Virtual Assistant - MarketsandMarkets

Home